Peringatan Keamanan

As with all sympathomimetic aerosol medication, cardiac arrest and even death may be associated with abuse of pirbuterol.

Pirbuterol

DB01291

small molecule approved

Deskripsi

Pirbuterol is a beta-2 adrenergic bronchodilator. In vitro studies and in vivo pharmacologic studies have demonstrated that pirbuterol has a preferential effect on beta-2 Adrenergic receptors compared with isoproterenol. While it is recognized that beta-2 adrenergic receptors are the predominant receptors in bronchial smooth muscle, data indicate that there is a population of beta-2 receptors in the human heart, existing in a concentration between 10-50%. The precise function of these receptors has not been established.

The pharmacologic effects of beta adrenergic agonist drugs, including pirbuterol, are at least in proof attributable to stimulation through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which catalyzes the conversion of adenosine triphosphate (AlP) to cyclic-3† ,5†-adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.

Struktur Molekul 2D

Berat 240.2988
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 2 hours.
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

787 Data
Loxapine The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Loxapine.
Valsartan Pirbuterol may decrease the antihypertensive activities of Valsartan.
Ramipril Pirbuterol may decrease the antihypertensive activities of Ramipril.
Reserpine Pirbuterol may decrease the antihypertensive activities of Reserpine.
Remikiren Pirbuterol may decrease the antihypertensive activities of Remikiren.
Isradipine Pirbuterol may decrease the antihypertensive activities of Isradipine.
Olmesartan Pirbuterol may decrease the antihypertensive activities of Olmesartan.
Nitroprusside Pirbuterol may decrease the antihypertensive activities of Nitroprusside.
Diltiazem Pirbuterol may decrease the antihypertensive activities of Diltiazem.
Minoxidil Pirbuterol may decrease the antihypertensive activities of Minoxidil.
Treprostinil Pirbuterol may decrease the antihypertensive activities of Treprostinil.
Amlodipine Pirbuterol may decrease the antihypertensive activities of Amlodipine.
Nimodipine Pirbuterol may decrease the antihypertensive activities of Nimodipine.
Nisoldipine Pirbuterol may decrease the antihypertensive activities of Nisoldipine.
Fosinopril Pirbuterol may decrease the antihypertensive activities of Fosinopril.
Trandolapril Pirbuterol may decrease the antihypertensive activities of Trandolapril.
Lercanidipine Pirbuterol may decrease the antihypertensive activities of Lercanidipine.
Benazepril Pirbuterol may decrease the antihypertensive activities of Benazepril.
Bosentan Pirbuterol may decrease the antihypertensive activities of Bosentan.
Enalapril Pirbuterol may decrease the antihypertensive activities of Enalapril.
Candoxatril Pirbuterol may decrease the antihypertensive activities of Candoxatril.
Mecamylamine Pirbuterol may decrease the antihypertensive activities of Mecamylamine.
Losartan Pirbuterol may decrease the antihypertensive activities of Losartan.
Moexipril Pirbuterol may decrease the antihypertensive activities of Moexipril.
Eplerenone Pirbuterol may decrease the antihypertensive activities of Eplerenone.
Lisinopril Pirbuterol may decrease the antihypertensive activities of Lisinopril.
Nitroglycerin Pirbuterol may decrease the antihypertensive activities of Nitroglycerin.
Metyrosine Pirbuterol may decrease the antihypertensive activities of Metyrosine.
Cryptenamine Pirbuterol may decrease the antihypertensive activities of Cryptenamine.
Perindopril Pirbuterol may decrease the antihypertensive activities of Perindopril.
Candesartan cilexetil Pirbuterol may decrease the antihypertensive activities of Candesartan cilexetil.
Fenoldopam Pirbuterol may decrease the antihypertensive activities of Fenoldopam.
Tadalafil Pirbuterol may decrease the antihypertensive activities of Tadalafil.
Eprosartan Pirbuterol may decrease the antihypertensive activities of Eprosartan.
Quinapril Pirbuterol may decrease the antihypertensive activities of Quinapril.
Telmisartan Pirbuterol may decrease the antihypertensive activities of Telmisartan.
Methyldopa Pirbuterol may decrease the antihypertensive activities of Methyldopa.
Irbesartan Pirbuterol may decrease the antihypertensive activities of Irbesartan.
Nitrendipine Pirbuterol may decrease the antihypertensive activities of Nitrendipine.
Deserpidine Pirbuterol may decrease the antihypertensive activities of Deserpidine.
Pentolinium Pirbuterol may decrease the antihypertensive activities of Pentolinium.
Trimethaphan Pirbuterol may decrease the antihypertensive activities of Trimethaphan.
Diazoxide Pirbuterol may decrease the antihypertensive activities of Diazoxide.
Captopril Pirbuterol may decrease the antihypertensive activities of Captopril.
Epoprostenol Pirbuterol may decrease the antihypertensive activities of Epoprostenol.
Bepridil Pirbuterol may decrease the antihypertensive activities of Bepridil.
Hydralazine Pirbuterol may decrease the antihypertensive activities of Hydralazine.
Cilazapril Pirbuterol may decrease the antihypertensive activities of Cilazapril.
Saprisartan Pirbuterol may decrease the antihypertensive activities of Saprisartan.
Spirapril Pirbuterol may decrease the antihypertensive activities of Spirapril.
Mibefradil Pirbuterol may decrease the antihypertensive activities of Mibefradil.
Tienilic acid Pirbuterol may decrease the antihypertensive activities of Tienilic acid.
Debrisoquine Pirbuterol may decrease the antihypertensive activities of Debrisoquine.
Sitaxentan Pirbuterol may decrease the antihypertensive activities of Sitaxentan.
Ambrisentan Pirbuterol may decrease the antihypertensive activities of Ambrisentan.
Diethylnorspermine Pirbuterol may decrease the antihypertensive activities of Diethylnorspermine.
Nilvadipine Pirbuterol may decrease the antihypertensive activities of Nilvadipine.
Pinacidil Pirbuterol may decrease the antihypertensive activities of Pinacidil.
Temocapril Pirbuterol may decrease the antihypertensive activities of Temocapril.
Riociguat Pirbuterol may decrease the antihypertensive activities of Riociguat.
Macitentan Pirbuterol may decrease the antihypertensive activities of Macitentan.
Hexamethonium Pirbuterol may decrease the antihypertensive activities of Hexamethonium.
Aliskiren Pirbuterol may decrease the antihypertensive activities of Aliskiren.
Nicorandil Pirbuterol may decrease the antihypertensive activities of Nicorandil.
Efonidipine Pirbuterol may decrease the antihypertensive activities of Efonidipine.
Lacidipine Pirbuterol may decrease the antihypertensive activities of Lacidipine.
Manidipine Pirbuterol may decrease the antihypertensive activities of Manidipine.
Rauwolfia serpentina root Pirbuterol may decrease the antihypertensive activities of Rauwolfia serpentina root.
Enalaprilat Pirbuterol may decrease the antihypertensive activities of Enalaprilat.
Selexipag Pirbuterol may decrease the antihypertensive activities of Selexipag.
Angiotensin 1-7 Pirbuterol may decrease the antihypertensive activities of Angiotensin 1-7.
Imidapril Pirbuterol may decrease the antihypertensive activities of Imidapril.
BQ-123 Pirbuterol may decrease the antihypertensive activities of BQ-123.
Tetrahydropalmatine Pirbuterol may decrease the antihypertensive activities of Tetrahydropalmatine.
Cicletanine Pirbuterol may decrease the antihypertensive activities of Cicletanine.
Dihydralazine Pirbuterol may decrease the antihypertensive activities of Dihydralazine.
Zofenopril Pirbuterol may decrease the antihypertensive activities of Zofenopril.
Guanoxan Pirbuterol may decrease the antihypertensive activities of Guanoxan.
Delapril Pirbuterol may decrease the antihypertensive activities of Delapril.
Vincamine Pirbuterol may decrease the antihypertensive activities of Vincamine.
Linsidomine Pirbuterol may decrease the antihypertensive activities of Linsidomine.
Guanoxabenz Pirbuterol may decrease the antihypertensive activities of Guanoxabenz.
Tolonidine Pirbuterol may decrease the antihypertensive activities of Tolonidine.
Endralazine Pirbuterol may decrease the antihypertensive activities of Endralazine.
Cadralazine Pirbuterol may decrease the antihypertensive activities of Cadralazine.
Bietaserpine Pirbuterol may decrease the antihypertensive activities of Bietaserpine.
Guanazodine Pirbuterol may decrease the antihypertensive activities of Guanazodine.
Methoserpidine Pirbuterol may decrease the antihypertensive activities of Methoserpidine.
Guanoclor Pirbuterol may decrease the antihypertensive activities of Guanoclor.
Muzolimine Pirbuterol may decrease the antihypertensive activities of Muzolimine.
Xipamide Pirbuterol may decrease the antihypertensive activities of Xipamide.
Candesartan Pirbuterol may decrease the antihypertensive activities of Candesartan.
Dexniguldipine Pirbuterol may decrease the antihypertensive activities of Dexniguldipine.
Tocopherylquinone Pirbuterol may decrease the antihypertensive activities of Tocopherylquinone.
Benazeprilat Pirbuterol may decrease the antihypertensive activities of Benazeprilat.
Fosinoprilat Pirbuterol may decrease the antihypertensive activities of Fosinoprilat.
Ramiprilat Pirbuterol may decrease the antihypertensive activities of Ramiprilat.
Perindoprilat Pirbuterol may decrease the antihypertensive activities of Perindoprilat.
Quinaprilat Pirbuterol may decrease the antihypertensive activities of Quinaprilat.
Felodipine Pirbuterol may decrease the antihypertensive activities of Felodipine.

Target Protein

Beta-2 adrenergic receptor ADRB2
Beta-1 adrenergic receptor ADRB1

Referensi & Sumber

Synthesis reference: Berkeley W. Cue, Stephen S. Massett, "Intermediates for preparing pirbuterol and analogs." U.S. Patent US4632992, issued June, 1977.

Contoh Produk & Brand

Produk: 6 • International brands: 0
Produk
  • Maxair
    Aerosol, metered • 200 ug/1 • Respiratory (inhalation) • US • Approved
  • Maxair
    Aerosol, metered • 200 ug/1 • Respiratory (inhalation) • US • Approved
  • Maxair Aem 240mcg/aem
    Aerosol, metered • 250 mcg / act • Respiratory (inhalation) • Canada • Approved
  • Maxair Autohaler
    Inhalant • 200 ug/1 • Oral • US • Approved
  • Maxair Autohaler
    Inhalant • 200 ug/1 • Oral • US • Approved
  • Maxair Autohaler
    Inhalant • 200 ug/1 • Respiratory (inhalation) • US • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul